Holocene Advisors’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51M Buy
203,621
+75,904
+59% +$18.9M 0.12% 181
2025
Q4
$35.1M Sell
127,717
-59,394
-32% -$16.2M 0.07% 245
2025
Q3
$49.1M Buy
+187,111
New +$45.5M 0.11% 176
2025
Q2
Sell
-2,831
Closed -$634K 898
2025
Q1
$634K Sell
2,831
-8,396
-75% -$2.31M ﹤0.01% 655
2024
Q4
$3.68M Sell
11,227
-98,213
-90% -$30.9M 0.01% 450
2024
Q3
$32.8M Sell
109,440
-76,693
-41% -$23.5M 0.13% 184
2024
Q2
$61.3M Sell
186,133
-170,875
-48% -$60.4M 0.26% 118
2024
Q1
$141M Buy
+357,008
New +$132M 0.52% 66
2023
Q4
Sell
-17,757
Closed -$6.66M 853
2023
Q3
$6.66M Buy
+17,757
New +$6.87M 0.03% 336
2019
Q3
Sell
-11,623
Closed -$1.46M 876
2019
Q2
$1.46M Sell
11,623
-438
-4% -$51.7K 0.02% 223
2019
Q1
$1.33M Buy
12,061
+3,665
+44% +$381K 0.02% 201
2018
Q4
$823K Buy
8,396
+4,255
+103% +$462K 0.01% 302
2018
Q3
$511K Sell
4,141
-1,105
-21% -$124K 0.01% 539
2018
Q2
$521K Sell
5,246
-1,320
-20% -$122K 0.01% 157
2018
Q1
$580K Buy
6,566
+3,902
+146% +$365K 0.01% 149
2017
Q4
$263K Buy
+2,664
New +$261K 0.01% 565

Other funds holding WST